Fox Jonathan C - Oct 1, 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C
Stock symbol
EWTX
Transactions as of
Oct 1, 2025
Transactions value $
$0
Form type
4
Date filed
10/2/2025, 08:29 PM
Previous filing
Jul 2, 2025
Next filing
Nov 13, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fox Jonathan C Director C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER /s/ John R. Moore, Attorney-in-Fact for Fox Jonathan C 2025-10-02 0001655016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Award $0 +728 +5.93% $0.00 13K Oct 1, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. (the "Issuer") common stock, granted and released to the reporting person on October 1, 2025, as a Quarterly Retainer Award pursuant to Section 2.4 of the Issuer's Outside Director Compensation Policy, as amended.